caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1992741177

Thomas SollecitoDMD

Maxillofacial SurgeryRadnor, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Thomas Sollecito's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
2872
PHILADELPHIA POST ACUTE PARTNERS, LLC2499
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
1439
PRESBYTERIAN MEDICAL CENTER OF THE UNIVERSITY OF PENNSYLVANIA HEALTH S1332
MAIN LINE HOSPITALS, INC.1241
THE PENNSYLVANIA HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA HEALTH SYS1122
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
374
Unique beneficiaries
—
Total services
614
Distinct HCPCS
5
Medicare payment
$38K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 48 Maxillofacial Surgery providers in PA — top quintile (cohort median 80).
PRESCRIBING · PART D · 2024
Total Rx claims
859
Beneficiaries
—
Total drug cost
$42K
Distinct drugs
12
Brand share
25.7%
Top prescribed drugs
Doxycycline Hyclate188 claims
Nystatin136 claims
Fluoride (Sodium)130 claims
Dexamethasone126 claims
Clotrimazole86 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
73.6
Cost
76.1
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.42%
Group